A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU)

Clinical trial NCT06817343 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06817343
Sponsor: Exegenesis Bio
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neovascular Age-Related Macular Degeneration (nAMD)Neovascular (Wet) Age-related Macular Degeneration (AMD)

Start date: 2024-09-10
Primary completion: 2029-02-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.